Remove 2026 Remove HIV Treatment and Prevention Agents Remove Immunization
article thumbnail

Iftaar and Insulin: Managing Diabetes During Ramadan

Pharmacy Times

These technologies prevent the risk of both hypo- and hyperglycemic episodes, facilitating safer fasting. Nieto is a 2026 PharmD Candidate at the University of Connecticut School of Pharmacy in Storrs, CT. The guidance is updated every 5 years, with the most recent update published in May 2025. About the Author Amy C.

article thumbnail

Procedure Shows Promise for Sustained Weight Loss After GLP-1 Therapy

Drug Topics

1,2 “There is an extraordinary unmet need in obesity treatment, which is the ability for patients to stop GLP-1 drugs without regaining weight. 1 “These early Revita data are better than I expected and suggest the potential to prevent the weight regain we see in practice. 1 REFERENCES 1. Fractyl Health. News release. June 23, 2025.